Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysteroscopy Practice

• Status: Completed
• Trial end date: 2009-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to demonstrate that Lidocaine-Prilocaine cream decrease pain during hysteroscopy diagnostic practice.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Consorci Sanitari de Terrassa
• Treatments: EMLA; Lidocaine; Lidocaine, Prilocaine Drug Combination; Prilocaine

Criteria

Inclusion Criteria:

• patients that he must perform a diagnostic hysteroscopy

• acceptance to participate in the study signed informed consent

Exclusion Criteria prerandomization:

• hypersensitivity or allergy to anesthetics

• refusal of the patient

• patients under age 18 and pregnant

Exclusion Criteria postrandomization:

• dropout

• unbearable pain that involves other analgesic measures

• allergic reactions to topical anesthetics